BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7839 related articles for article (PubMed ID: 19575957)

  • 1. [What else can we do for uveal melanoma].
    Li B; Xu XL
    Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of intraocular melanoma: new concepts].
    De Potter P
    Bull Mem Acad R Med Belg; 2003; 158(1-2):103-11; discussion 111-2. PubMed ID: 12852096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selected prognostic factors of malignant uveal melanoma].
    Svetlosáková Z; Krásnik V; Gergisáková H; Babál P; Kusenda P
    Cesk Slov Oftalmol; 2012 Feb; 68(1):38-42. PubMed ID: 22679696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic uveal melanoma.
    Singh AD; Borden EC
    Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors of extraocular spread after local treatment of uveal melanoma].
    Neroev VV; Saakian SV; Amirian AG; Val'skiĭ VV
    Vestn Oftalmol; 2011; 127(2):21-5. PubMed ID: 21721267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant melanoma of the uvea].
    Boaziz C; Mazeron JJ; Morere JF; Breau JL; Israël L
    Bull Cancer; 1993 Jul; 80(7):577-83. PubMed ID: 8204938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic uveal melanoma: diagnosis and treatment. A literature review.
    De Croock L; Verbraeken H
    Bull Soc Belge Ophtalmol; 2002; (286):59-63. PubMed ID: 12564318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional management of hepatic metastasis from primary uveal melanoma.
    Sato T
    Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for uveal melanoma metastasis. Literature review.
    Missotten GS; Keunen JE
    Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary intraocular cancers: retinoblastoma and uveal malignant melanoma.
    Boyd-Monk H; Augsburger JJ
    J Ophthalmic Nurs Technol; 1997; 16(4):183-7. PubMed ID: 9335732
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 392.